Mimotopes Pty Ltd, established in Melbourne, Australia in 1988, is recognized as one of the first combinatorial chemistry companies formed and an industry leader in the peptide and discovery chemistry sector. The pioneering work of Dr. Mario Geysen enabled the parallel synthesis of peptides and subsequently small molecules to become mainstream.
Mimotopes develops, markets and distributes sophisticated biochemical products and services for the biotech and pharmaceutical industries. Mimotopes uses proprietary technologies in solid phase synthesis, molecule scavenging applications and biomolecular capture and immobilisation. Mimotopes’ expertise in
polymer chemistry has enabled it to launched the most respected and advanced solid phase synthesis platforms for solid phase synthesis of drug-like molecules (SynPhaseTM Lanterns). Mimotopes is the preeminent epitope mapping company covering all forms of B- and T-cell epitope mapping for drug discovery and vaccine research making important contributions in developing diagnostics and vaccine candidates.
